Overview
Hiroaki Senju practices in Sasebo, Japan. Mr. Senju is rated as an Experienced expert by MediFind in the treatment of Chondrosarcoma. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Metastatic Pleural Tumor, and Febrile Neutropenia.
His clinical research consists of co-authoring 32 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Chondrosarcoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung CancerMr. Senju isAdvanced. Learn about Lung Cancer.
- Small Cell Lung Cancer (SCLC)Mr. Senju isAdvanced. Learn about Small Cell Lung Cancer (SCLC).
- Experienced
- AgranulocytosisMr. Senju isExperienced. Learn about Agranulocytosis.
- ChondrosarcomaMr. Senju isExperienced. Learn about Chondrosarcoma.
- EGFR Positive Lung CancerMr. Senju isExperienced. Learn about EGFR Positive Lung Cancer.
- Febrile NeutropeniaMr. Senju isExperienced. Learn about Febrile Neutropenia.
- Lung MetastasesMr. Senju isExperienced. Learn about Lung Metastases.
- Mediastinal TumorMr. Senju isExperienced. Learn about Mediastinal Tumor.